Brief: Nektar Therapeutics Increases Authorized Shares To 390 Million
06/06/2025 21:35
June 6 (Reuters) - Nektar Therapeutics NKTR.O: NEKTAR THERAPEUTICS - INCREASES AUTHORIZED SHARES TO 390 MILLION - SEC FILING Further company coverage: NKTR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nektar Therapeutics
See all newsBrief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment
U.S. STOCKS ON THE MOVEx-Microsoft, 3M, Twilio
U.S. STOCKS ON THE MOVEx-Microsoft, Nike, Nektar Therapeutics
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says